Annual Shareholders Equity
-$1.87 M
-$7.49 M-133.35%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual stockholders equity is -$1.87 million, with the most recent change of -$7.49 million (-133.35%) on December 1, 2023.
- During the last 3 years, NRSN annual shareholders equity has fallen by -$2.53 million (-384.37%).
- NRSN annual shareholders equity is now -120.81% below its all-time high of $9.01 million, reached on December 31, 2021.
Performance
NRSN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$2.82 M
-$1.11 M-65.47%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly stockholders equity is -$2.82 million, with the most recent change of -$1.11 million (-65.47%) on September 1, 2024.
- Over the past year, NRSN quarterly shareholders equity has increased by +$4.17 million (+59.70%).
- NRSN quarterly shareholders equity is now -123.28% below its all-time high of $12.11 million, reached on March 31, 2022.
Performance
NRSN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NRSN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -133.3% | +59.7% |
| 3 y3 years | -384.4% | -128.7% |
| 5 y5 years | -304.1% | - |
NRSN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -120.8% | at low | -123.3% | +59.7% |
| 5 y | 5-year | -120.8% | at low | -123.3% | +59.7% |
| alltime | all time | -120.8% | at low | -123.3% | +59.7% |
NeuroSense Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$2.82 M(+65.5%) |
| Jun 2024 | - | -$1.70 M(-75.6%) |
| Mar 2024 | - | -$6.99 M(+273.2%) |
| Dec 2023 | -$1.87 M(-133.4%) | -$1.87 M(+856.1%) |
| Sep 2023 | - | -$196.00 K(-87.3%) |
| Jun 2023 | - | -$1.54 M(-153.5%) |
| Mar 2023 | - | $2.89 M(-48.6%) |
| Dec 2022 | $5.62 M | $5.62 M(-28.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.85 M(-20.2%) |
| Jun 2022 | - | $9.84 M(-18.8%) |
| Mar 2022 | - | $12.11 M(+34.4%) |
| Dec 2021 | $9.01 M(+1266.6%) | - |
| Dec 2021 | - | $9.01 M(+861.2%) |
| Jun 2021 | - | $937.00 K(+42.2%) |
| Dec 2020 | $659.00 K(-28.2%) | $659.00 K |
| Dec 2019 | $918.00 K | - |
FAQ
- What is NeuroSense Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual shareholders equity year-on-year change?
- What is NeuroSense Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly shareholders equity year-on-year change?
What is NeuroSense Therapeutics annual stockholders equity?
The current annual shareholders equity of NRSN is -$1.87 M
What is the all time high annual shareholders equity for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual stockholders equity is $9.01 M
What is NeuroSense Therapeutics annual shareholders equity year-on-year change?
Over the past year, NRSN annual stockholders equity has changed by -$7.49 M (-133.35%)
What is NeuroSense Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NRSN is -$2.82 M
What is the all time high quarterly shareholders equity for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly stockholders equity is $12.11 M
What is NeuroSense Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, NRSN quarterly stockholders equity has changed by +$4.17 M (+59.70%)